https://www.selleckchem.com/products/gm6001.html
Cisplatin-associated electrolyte dysregulation is a prevalent therapy-related adverse effect. There are numerous electrolyte-supplemented hydration regimens that have been evaluated, however these studies focused on the development of nephrotoxicity. The objective of this study was to characterize the impact of magnesium and potassium-supplemented hydration during cisplatin administration on subsequent magnesium and potassium imbalances. A single-region retrospective study from central Texas at Baylor Scott White Cancer Clinics who
Like
Comment
Share
